… However, they should also be informed that most malignancy subtypes are possibly
preventable by controlling intestinal inflammation and by using adequate screening strategies. …

… able to identify 800 patients with inflammatory bowel disease diagnosed before 1965 within
the … All malignancies diagnosed before the diagnosis of inflammatory bowel disease were …

… and malignancy. Methods: Review of the literature. Results: In UC, the extent of the disease,
… disease and the development of CRC or other malignancies. Only the development of small-…

Patients with inflammatory bowel diseases (IBDs) are at increased risk of colorectal cancer (CRC),
but the risk varies between different studies and seems to be decreasing. The …

… Malignancy may occur as long-term complication of inflammatory bowel disease (IBD) due
to … We assessed prevalence and incidence of malignancy, and predictive factors in the Swiss …

… of malignancy for use in inflammatory bowel disease cancer … of the risk of malignancy in
inflammatory bowel disease and have set … of malignancy in inflammatory bowel disease cancer …

… [UC] are chronic relapsing inflammatory diseases of the gastrointestinal tract collectively
called inflammatory bowel disease [IBD]. The causes of the diseases remain unknown. Typically…

… long-term complications in patients with inflammatory bowel disease (IBD), likely as a result
… used to control inflammation. Here, we assessed the frequency of malignancies in a large …

… inflammatory bowel disease and cancer. MeSH terms and/or text words included the broad
… inflammatory bowel disease, cancer, malignancy, Crohn’s disease, and ulcerative colitis. We …

… ] and malignancy in patients with inflammatory bowel disease [IBD] is not well understood.
Our aim was to systematically evaluate the impact of TNFi use on risk of malignancy in IBD …